Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans

Mutations in the DNA/RNA binding proteins TDP-43 and FUS are associated with Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Intracellular accumulations of wild type TDP-43 and FUS are observed in a growing number of late-onset diseases suggesting that TDP-43 and FUS proteinopathies may contribute to multiple neurodegenerative diseases. To better understand the mechanisms of TDP-43 and FUS toxicity we have created transgenic Caenorhabditis elegans strains that express full-length, untagged human TDP-43 and FUS in the worm's GABAergic motor neurons. Transgenic worms expressing mutant TDP-43 and FUS display adult-onset, age-dependent loss of motility, progressive paralysis and neuronal degeneration that is distinct from wild type alleles. Additionally, mutant TDP-43 and FUS proteins are highly insoluble while wild type proteins remain soluble suggesting that protein misfolding may contribute to toxicity. Populations of mutant TDP-43 and FUS transgenics grown on solid media become paralyzed over 7 to 12 days. We have developed a liquid culture assay where the paralysis phenotype evolves over several hours. We introduce C. elegans transgenics for mutant TDP-43 and FUS motor neuron toxicity that may be used for rapid genetic and pharmacological suppressor screening.

[1]  N. Shneider,et al.  The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. , 2011, The Journal of clinical investigation.

[2]  T. Kawano,et al.  ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism , 2011, Human molecular genetics.

[3]  J. Julien,et al.  Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. , 2011, Brain : a journal of neurology.

[4]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[5]  E. Brustein,et al.  FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis , 2011, PLoS genetics.

[6]  Pico Caroni,et al.  Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.

[7]  Ji Han Kim,et al.  A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. , 2011, Human molecular genetics.

[8]  Daniel F Tardiff,et al.  A Yeast Model of FUS/TLS-Dependent Cytotoxicity , 2011, PLoS biology.

[9]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[10]  Jiou Wang,et al.  TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. , 2011, Human molecular genetics.

[11]  Nicole F. Liachko,et al.  Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy , 2010, The Journal of Neuroscience.

[12]  I. Mackenzie,et al.  TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia , 2010, The Lancet Neurology.

[13]  R. Tibbetts,et al.  Amyotrophic Lateral Sclerosis-associated Proteins TDP-43 and FUS/TLS Function in a Common Biochemical Complex to Co-regulate HDAC6 mRNA* , 2010, The Journal of Biological Chemistry.

[14]  H. Hutter,et al.  Neurotoxic effects of TDP-43 overexpression in C. elegans. , 2010, Human molecular genetics.

[15]  David M. Miller,et al.  Coenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration , 2010, Proceedings of the National Academy of Sciences.

[16]  Huilin Zhou,et al.  ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS , 2010, Proceedings of the National Academy of Sciences.

[17]  D. Cleveland,et al.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. , 2010, Human molecular genetics.

[18]  G. Rouleau,et al.  Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. , 2010, Human molecular genetics.

[19]  Jane Y. Wu,et al.  A Drosophila model for TDP-43 proteinopathy , 2010, Proceedings of the National Academy of Sciences.

[20]  G. Rouleau,et al.  Genetics of motor neuron disorders: new insights into pathogenic mechanisms , 2009, Nature Reviews Genetics.

[21]  V. Meininger,et al.  Mutations in FUS cause FALS and SALS in French and French Canadian populations , 2009, Neurology.

[22]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[23]  D. Hall,et al.  An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans , 2009, PLoS genetics.

[24]  B. Brais,et al.  Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1. , 2008, Human molecular genetics.

[25]  M. Kiernan,et al.  Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. , 2008, Brain : a journal of neurology.

[26]  B. Kennedy,et al.  Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf‐1‐dependent mechanism in Caenorhabditis elegans , 2008, Aging cell.

[27]  Michael Dybbs,et al.  An RNAi Screen Identifies Genes that Regulate GABA Synapses , 2008, Neuron.

[28]  B. McConkey,et al.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis , 2008, Nature Genetics.

[29]  S. Lindquist,et al.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity , 2008, Proceedings of the National Academy of Sciences.

[30]  C. Lomen‐Hoerth,et al.  Amyotrophic Lateral Sclerosis from Bench to Bedside , 2008, Seminars in neurology.

[31]  J. Morris,et al.  TDP‐43 A315T mutation in familial motor neuron disease , 2008, Annals of neurology.

[32]  Xun Hu,et al.  TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.

[33]  James J Collins,et al.  The measurement and analysis of age-related changes in Caenorhabditis elegans. , 2008, WormBook : the online review of C. elegans biology.

[34]  Randy D Blakely,et al.  Vigorous Motor Activity in Caenorhabditis elegans Requires Efficient Clearance of Dopamine Mediated by Synaptic Localization of the Dopamine Transporter DAT-1 , 2007, The Journal of Neuroscience.

[35]  Timothy R Mahoney,et al.  Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay , 2006, Nature Protocols.

[36]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[37]  D. Cleveland,et al.  ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors , 2006, Neuron.

[38]  Ehud Cohen,et al.  Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.

[39]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[40]  Thomas C. Evans,et al.  Transformation and microinjection , 2006 .

[41]  Theresa Stiernagle Maintenance of C. elegans. , 2006, WormBook : the online review of C. elegans biology.

[42]  Oliver Hobert,et al.  A Conserved Postsynaptic Transmembrane Protein Affecting Neuromuscular Signaling in Caenorhabditis elegans , 2004, The Journal of Neuroscience.

[43]  D. Hall,et al.  Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans , 2002, Nature.

[44]  G. Bernardi,et al.  Pharmacologic reversal of cortical hyperexcitability in patients with ALS , 2000, Neurology.

[45]  E. Jorgensen,et al.  Identification and characterization of the vesicular GABA transporter , 1997, Nature.

[46]  H. Horvitz,et al.  The GABAergic nervous system of Caenorhabditis elegans , 1993, Nature.

[47]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.